Maze Therapeutics (MAZE) plunged ~37% on Wednesday despite reporting encouraging initial data from a Phase 2 trial for its lead asset, MZE829, targeted at broad APOL1-mediated kidney disease, a ...
A Canadian who has worked in the gaming industry for over two decades, Beck grew up on games such as Final Fantasy and Super Mario Bros. He specalizes in roleplaying games, but covers titles in almost ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
- At week 12, treatment with MZE829 resulted in a 35.6% mean uACR reduction in broad AMKD patients, 50% of the patients achieved a greater than 30% reduction in uACR, and treatment was well-tolerated ...
Richard Nixon’s tempestuous first term as President of the United States (1968-72) caused despair among America’s artistic community. Last week's sale of the David and Peggy Rockefeller collection at ...
For decades, Marilyn Monroe's missing 'red diary' has belonged to the realm of Hollywood myth - one more tantalizing object said to have vanished into the darkness after the screen icon's death. But ...
During the glacial period that chilled the Earth 140,000 years ago, sea levels in the Indonesian region of Sundaland were low enough for present-day islands to tower like mountain ranges with a ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Maze Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results